Fetal Therapy: Current Status and Future Directions â?? A Stanford Symposium
This multidisciplinary symposium hosted by the Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact and the Department of Obstetrics and Gynecology will spotlight the most up-to-date basic, translational and clinical research on fetal medicine and therapy. Attendees will learn about cutting-edge investigations around perinatal origins of disease to potential interventions involving gene editing and stem cell therapies. The goal of the symposium is to promote creative collaborations across the Stanford community interested in making an impact on the lives of expectant mothers, children and families â?? locally and globally.
This event is free and open to the Stanford community.Â The symposium will be held virtually via Zoom; registration is required.Â
Opening Remarks: Yair Blumenfeld, MDÂ
Dr. Blumenfeld is the director of Fetal Therapy at Lucile Packard Childrenâ??s Hospital Stanford, and has been involved in multidisciplinary clinical and translational research for over 10 years. Dr. Blumenfeldâ??s research focus is new technologies in prenatal diagnosis and fetal therapy, as well as clinical obstetrics and prematurity.
Session 1: Organ Development
- David Cornfield, MDÂ
- Karl Sylvester, MDÂ
- Anca Pasca, MDÂ
Session 2: Stem Cell and Gene Editing Therapies
- Maria Grazia Roncarolo, MD
- Agnieszka Czechowicz, MD, PhD
- Kyle Cromer, PhD and Carsten Charlesworth
Session 3: Medical Therapies
- John Day, MD, PhD
- Paul Wender, PhD